Inventor profile of:

Mark K. BENNETT

City:

Moraga, California

Country:

United States

Published Applications:

45

Last publication date:

2019-08-01

Top Assignees for applications by Mark K. BENNETT

The entities that hold a legal rights for patent applications filed by inventor BENNETT Mark K.:

Recent patent applications by BENNETT Mark K.

Mark K. BENNETT from Moraga, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-08-01
US20190231776A1
Human necessities

Combination therapy with glutaminase inhibitors and immuno-oncology agents

#2 | 2018-03-01
US20180055842A1
Human necessities

Combination therapy with glutaminase inhibitors

#3 | 2017-04-06
US20170095473A1
Human necessities

Combination therapy with glutaminase inhibitors and immuno-oncology agents

#4 | 2016-10-06
US20160287564A1
Human necessities

METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS

#5 | 2015-01-01
US20150004134A1
Chemistry; metallurgy

TREATMENT OF CANCER WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE

#6 | 2014-04-10
US20140100169A1
Chemistry; metallurgy

COMPOUNDS FOR ENZYME INHIBITION

#7 | 2014-03-20
US20140080753A1
Chemistry; metallurgy

COMPOUNDS FOR ENZYME INHIBITION

#8 | 2013-12-19
US20130338057A1
Chemistry; metallurgy

Compounds for enzyme inhibition

#9 | 2013-03-21
US20130072422A1
Chemistry; metallurgy

Compounds for immunoproteasome inhibition

#10 | 2013-02-28
US20130053303A1
Human necessities

Compounds for enzyme inhibition

#11 | 2013-02-14
US20130041008A1
Human necessities

Compounds for enzyme inhibition

#12 | 2013-02-07
US20130035297A1
Human necessities

Compounds for enzyme inhibition

#13 | 2012-04-12
US20120088762A1
Human necessities

Compounds for enzyme inhibition

#14 | 2011-09-29
US20110236428A1
Human necessities

COMBINATION THERAPY WITH PEPTIDE EPOXYKETONES

#15 | 2010-08-05
US20100196346A1
Physics

Substrate for Rpn 11 enzymatic activity

#16 | 2010-06-10
US20100144649A1
Human necessities

Compounds for enzyme inhibition

#17 | 2010-06-10
US20100144648A1
Human necessities

Compounds for enzyme inhibition

#18 | 2009-08-27
US20090215093A1
Chemistry; metallurgy

COMPOUNDS FOR ENZYME INHIBITION

#19 | 2008-10-23
US20080261819A1
Chemistry; metallurgy

In vivo production of cyclic peptides for inhibiting protein-protein interaction

#20 | 2008-09-16
US10098243
-

Compounds that modulate processes associated with IgE production

#21 | 2008-05-27
US10197962
-

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein

#22 | 2008-05-20
US10197945
-

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein

#23 | 2008-05-08
US20080108066A1
Chemistry; metallurgy

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

#24 | 2008-01-10
US20080009076A1
Physics

Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)

#25 | 2008-01-03
US20080003620A1
Chemistry; metallurgy

METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING AN ADENOSINE KINASE

#26 | 2008-01-03
US20080003618A1
Physics

METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN

#27 | 2007-12-27
US20070298440A1
Physics

Method for identifying compounds that modulate RXR associated processes with IgE production

#28 | 2007-12-27
US20070298437A1
Chemistry; metallurgy

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein

#29 | 2007-12-20
US20070293465A1
Human necessities

Compounds for enzyme inhibition

#30 | 2007-10-18
US20070244033A1
Chemistry; metallurgy

METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A C-MYC PROTEIN

#31 | 2007-08-07
US10422536
-

In vivo production of cyclic peptides for inhibiting protein—protein interaction

#32 | 2007-07-10
US10222729
-

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein

#33 | 2007-06-14
US20070135350A1
Physics

Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing a B-Cell Associated Protein

#34 | 2007-05-10
US20070105140A1
Chemistry; metallurgy

In vivo production of cyclic peptides

#35 | 2007-03-13
US10197919
-

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein

#36 | 2007-03-08
US20070054862A1
Chemistry; metallurgy

Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing an Adenosine Kinase

#37 | 2006-12-14
US20060280731A1
Physics

Substrate for Rpn11 enzymatic activity

#38 | 2006-12-07
US20060276489A1
Chemistry; metallurgy

Inhibitors of Tubulin Polymerization

#39 | 2006-11-28
US10197381
-

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase

#40 | 2006-08-31
US20060193844A1
Human necessities

Methods for enzyme inhibition

#41 | 2006-07-04
US10369223
-

Inhibitors to tubulin polymerization

#42 | 2006-04-27
US20060088471A1
Chemistry; metallurgy

Compounds for enzyme inhibition

#43 | 2005-12-27
US10197368
-

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein

#44 | 2005-11-24
US20050260626A1
Chemistry; metallurgy

In vivo production of cyclic peptides for inhibiting protein-protein interaction

#45 | 2005-05-26
US20050112702A1
Chemistry; metallurgy

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

InventorID:

79841 ⎘